Rallybio Corp (NASDAQ:RLYB) shares, rose in value on Thursday, July 10, with the stock price down by -11.29% to the previous day’s close as strong demand from buyers drove the stock to $0.4.
Actively observing the price movement in the last trading, the stock closed the session at $0.45, falling within a range of $0.385 and $0.4494. The value of beta (5-year monthly) was -1.239. Referring to stock’s 52-week performance, its high was $1.54, and the low was $0.22. On the whole, RLYB has fluctuated by 5.66% over the past month.
With the market capitalization of Rallybio Corp currently standing at about $16.48 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RLYB’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of RLYB currently trading nearly 11.89% and 17.66% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.16, while the 7-day volatility ratio is showing 21.17% which for the 30-day chart, stands at 13.94%. Furthermore, Rallybio Corp (RLYB)’s beta value is -1.16.
A comparison of Rallybio Corp (RLYB) with its peers suggests the former has fared considerably weaker in the market. RLYB showed an intraday change of -11.29% in last session, and over the past year, it shrunk by -58.75%%.
Data on historical trading for Rallybio Corp (NASDAQ:RLYB) indicates that the trading volumes over the past 10 days have averaged 15.85 and over the past 3 months, they’ve averaged 2.72 million. According to company’s latest data on outstanding shares, there are 41.61 million shares outstanding.
Nearly 52.22% of Rallybio Corp’s shares belong to company insiders and institutional investors own 29.12% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.33 million shares as on 2025-06-13, resulting in a short ratio of 1.3. According to the data, the short interest in Rallybio Corp (RLYB) stood at 98.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 0.36 million. The stock has fallen by -69.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RLYB stock heading into the next quarter.
